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Background. Evidence of the presence of Plasmodium vivax in the placenta is scarce and inconclusive. This
information is relevant to understanding whether P. vivax affects placental function and how it may contribute to
poor pregnancy outcomes.
Methods. Histopathologic examination of placental biopsies from 80 Papua New Guinean pregnant women
was combined with quantitative polymerase chain reaction (qPCR) to conﬁrm P. vivax infection and rule out
coinfection with other Plasmodium species in placental and peripheral blood. Leukocytes and monocytes/macro-
phages were detected in placental sections by immunohistochemistry.
Results. Monoinfection by P. vivax and Plasmodium falciparum was detected by qPCR in 8 and 10 placentas,
respectively. Seven of the 8 women with P. vivax placental monoinfection were negative in peripheral blood. By
histology, 3 placentas with P. vivax monoinfection showed parasitized erythrocytes in the intervillous space but no
hemozoin in macrophages nor increased intervillous inﬂammatory cells. In contrast, 7 placentas positive for
P. falciparum presented parasites and hemozoin in macrophages or ﬁbrin as well as intervillous inﬂammatory
inﬁltrates.
Conclusions. Plasmodium vivax can be associated with placental infection. However, placental inﬂammation
is not observed in P. vivax monoinfections, suggesting other causes of poor delivery outcomes associated with
P. vivax infection.
Cytoadherence of erythrocytes infected by Plasmodi-
um falciparum has been shown to contribute to mi-
crovascular sequestration and to the high case fatality
rate of severe falciparum malaria [1]. In contrast, se-
questration of Plasmodium vivax within organs has
not been conﬁrmed in the very few autopsies and
tissue biopsies studied (reviewed in [2]). However,
recent reports showing adherence of P. vivax–infected
erythrocytes (IEs) to human receptors [2–4] suggest
the possibility that this parasite might also be able to
sequester in speciﬁc organs and tissues.
Histological evidence of P. vivax sequestration from
autopsies conducted at the beginning of the 1900s prece-
ded the possibility of molecular conﬁrmation of P. vivax
monoinfection [5, 6]. More recently, the postmortem
examination of a woman with fatal respiratory distress,
and polymerase chain reaction (PCR)–conﬁrmed
P. vivax infection showed heavy intravascular monocytic
inﬁltrates provoking inﬂammatory lesions in the endo-
thelium of the lungs, but without sequestration of IEs in
the pulmonary microvasculature [7], suggesting organ
damage unrelated to sequestration of P. vivax parasites.
In contrast to the considerable amount of data
showing accumulation of P. falciparum IEs in the
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intervillous spaces of the placenta [8], few reports have de-
scribed other Plasmodium species in placental smears [9–19].
However, there is a lack of studies combining histology and
molecular techniques in placental and peripheral blood to dis-
tinguish histological changes by Plasmodium species. Recently,
placental histology has demonstrated a deposition of hemo-
zoin associated with antenatal P. vivax infection among Karen
women from the Thai-Burmese border, although parasites
were rare or absent as antenatal care relied on active detection
and prompt treatment and P. vivax monoinfection was not
conﬁrmed by PCR [20]. In another study among pregnant
women residing in an area of Iquitos, Peru, with low transmis-
sion of P. vivax and P. falciparum, hemozoin deposition was
observed in 22% of the placentas analyzed [21], including a
cord blood infection and placental changes associated only
with P. vivax infection. Case reports have revealed the pres-
ence of P. vivax in the placenta by PCR, either alone or in
combination with P. falciparum, but they lacked histological
conﬁrmation [22, 23]. Although P. vivax infection has been
associated with adverse pregnancy outcomes [24], the patho-
physiological mechanisms underlying these adverse effects
remain to be determined.
Detailed histological and molecular studies describing
whether P. vivax parasites accumulate in human placentas and
the pathological changes associated with the infection are a
priority to understand how P. vivax can affect placental func-
tion and cause low birth weight [24], as well as to gain in-
sights into the general mechanisms of disease severity
associated with P. vivax malaria. The present study was under-
taken to determine if P. vivax can be unequivocally associated
with placental infection. To address this, we combined histo-
logical examination of placental samples with highly speciﬁc
PCR methods to conﬁrm P. vivax infection and rule out coin-
fection with other Plasmodium species.
MATERIALS AND METHODS
Study Site and Sample Collection
Pregnant women attending antenatal care at Alexishafen
Health Centre in Madang, Papua New Guinea, between
September 2005 and October 2007 were recruited in the
context of a longitudinal study of malaria in pregnancy, fol-
lowing written informed consent. The study area is character-
ized by year-round, high level malaria transmission. At the
time of the study, the prevalence of malaria in pregnant
women in Madang at ﬁrst antenatal care visit was 29%–41%
(with 5%–20% of these infections described as P. vivax by mi-
croscopy). At delivery, 7%–18% of women were positive in
their peripheral blood, and 16%–24% were placental smear
positive, with 4%–20% of these infections due to P. vivax [25].
The study was approved by the Papua New Guinea Medical
Research Advisory Council and by the Papua New Guinea
Institute of Medical Research Institutional Review Board. All
women participating in this study were prescribed chloroquine
as a treatment dose followed by weekly prophylaxis in
accordance with Papua New Guinea standard treatment guide-
lines; in the latter part of the study an initial dose of 3 tablets of
sulfadoxine-pyrimethamine was coadministered with chloro-
quine treatment, as recommended by the guidelines. Seventy-
ﬁve percent of women regularly used bed nets, but <10% of
these nets were insecticide-treated. Peripheral blood (6 mL) was
collected during labor or shortly after delivery in ethylenedi-
aminetetraacetic acid (EDTA) vacutainers. An incision was
made in a macroscopically normal area in the center of the ma-
ternal side of the placenta, and blood was collected from the in-
tervillous space with a sterile transfer pipette into an EDTA
vacutainer. From the same incision point, one placental biopsy
was collected and a full-thickness biopsy about 1 cm thick and
2 cm wide was placed in 10% neutral buffered formalin. Samples
collected from 80 pregnant women were included in the study.
Placental Histology
Placental samples (90–168 mm2) were processed for histologi-
cal examination and stained as previously described [26]. He-
matoxylin and eosin–stained slides from all placentas were
read independently by 2 pathologists. The following histologi-
cal ﬁndings were recorded in all cases: presence of Plasmodi-
um parasites, presence of hemozoin (identiﬁed by light
microscopy as a coarse, brown, granular material with bire-
fringency under polarized light) in free macrophages, presence
of hemozoin in ﬁbrin (either in macrophages covered by
ﬁbrin or free), and intervillous inﬂammation. Every case with
a discrepant result between both readings was subject to a
third blinded histological evaluation by one of the patholo-
gists. A 2-out-of-3 consensus evaluation was established after
this third evaluation. The percentage of IEs was established
after counting 500 intervillous erythrocytes.
Immunohistochemistry
Immunohistochemical studies were performed using the auto-
mated immunohistochemical system TechMate 500 TM (Dako)
and the EnVision system (Dako) in formalin-ﬁxed, parafﬁn-
embedded tissue. The total number of leukocytes was deter-
mined following staining with anti-CD45 (Clone 2B11, Dako)
and macrophages were stained with anti-CD68 (Clone KP1,
Dako). In brief, parafﬁn sections were deparafﬁnized and rehy-
drated in xylene and graded alcohols. After blocking with perox-
idase for 7.5 minutes in ChemMate peroxidase-blocking
solution (Dako), the slides were incubated with the primary an-
tibodies (CD45 and CD68) for 30 minutes and washed in
ChemMate buffer solution (Dako). After application of the per-
oxidase-labeled polymer for 30 minutes and washing, the slides
were incubated with the diaminobenzidine substrate chromogen
solution, washed in water, counterstained with hematoxylin,
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washed again, dehydrated, and mounted. The number of CD45-
and CD68-positive cells per high-power ﬁeld (HPF = ×400) was
calculated after counting 10 HPFs using an Olympus BX41 mi-
croscope (total area evaluated = 17.28 mm2).
DNA Template Extraction and Ampliﬁcation
After peripheral and placental blood centrifugation, DNA was
extracted from 200 μL of erythrocyte pellet using the QIAmp
DNA blood Mini Kit (Qiagen) and ﬁnally resuspended in
200 μL of distilled water according to the supplier’s instruc-
tions. Three microliters of extracted DNA was used for real-
time quantitative PCR (qPCR) following previously published
methods [27] with minor modiﬁcations. For optimal detection
of parasite genomic DNA, 25-μL simplex reactions were per-
formed for P. falciparum and P. vivax. Detection of Plasmodi-
um malariae and Plasmodium ovale was performed using a
duplex qPCR assay. Primers and probes corresponded to those
previously described with the exception of an improved P.
vivax probe, which has been changed to a minor groove
binder (MGB) probe (Life Technologies) with a 5′ VIC report-
er and a 3′ MGB nonﬂuorescent quencher to increase speciﬁc-
ity of P. vivax detection. Forty-ﬁve cycles were performed.
Positive and negative controls were included in the PCR exper-
iments. Positive controls consisted of a P. falciparum and P.
vivax amplicon cloned into plasmids. A standard curve of 10-
fold serial dilutions of these plasmids as well as no template
controls were included in each experiment. A sample was con-
sidered positive if the cycle threshold (Ct) value was <45.
Samples positive for Plasmodium species detected by qPCR
were conﬁrmed by PCR ligase detection reaction ﬂuorescent
microsphere assay (PCR-LDR-FMA) using 2.5 μL of DNA ex-
traction as described elsewhere [27].
Deﬁnitions and Statistical Analysis
A placental infection was deﬁned as unequivocally attributed
to P. vivax if placental blood was positive for P. vivax by
qPCR and PCR-LDR-FMA without evidence of coinfection
with P. falciparum, P. ovale, or P. malariae either in the pla-
centa or in peripheral blood by qPCR. The Kruskal-Wallis test
was used to compare Cts obtained from samples positive for
different Plasmodium species and the number of CD45+/
CD68+ cells in uninfected placentas with numbers in P. vivax
or P. falciparum monoinfected placentas.
RESULTS
The mean age of the 80 pregnant women included into the
study was 23.1 years (SD, 7.3). Twenty-seven of the women
(34%) were primigravidae. In 8 of the 80 women, qPCR re-
vealed P. vivax monoinfection in the placenta; 7 of these
women were negative in the peripheral blood for any Plasmo-
dium species, and 1 woman was positive for P. falciparum.
Ten of the women were positive for P. falciparum in the pla-
centa, 6 of whom were also positive for P. falciparum in pe-
ripheral blood. Only 1 mixed infection (P. falciparum plus
P. vivax) was found in placental blood (Table 1). Plasmodium
species–positive samples by qPCR were conﬁrmed by PCR-
LDR-FMA. Median Cts obtained by qPCR from placental
blood positive for P. falciparum (36.73 [interquartile range
{IQR}, 33.49–39.40]) were lower than Cts from P. vivax–
positive infections (42.83, [IQR, 41.09–44.53], P = .005). Plas-
modium ovale and P. malariae were not detected by qPCR in
any of the peripheral or placental blood samples tested.
On histological examination, 3 of the 8 placentas positive
for P. vivax by qPCR showed malarial parasites in the mater-
nal erythrocytes of the intervillous space, with parasitemias of
1%, 4%, and 25% (Figure 1A and 1B). All IEs showed mature
forms of the parasite containing hemozoin, but no hemozoin
was observed in free macrophages or in ﬁbrin. One of the 8
placentas had both malaria IEs (2% parasitized erythrocytes),
together with mild to moderate deposition of malarial
hemozoin in perivillous ﬁbrin (Figure 1C); this woman had a
P. falciparum infection in peripheral blood. Among the other
4 placentas not showing any parasite by histology, 3 presented
hemozoin in perivillous ﬁbrin. Hemozoin associated with
P. vivax infection, either in the cytoplasm of the parasite or in
ﬁbrin, showed birefringence under polarized light (Figure 1D).
No hemozoin within free macrophages was identiﬁed in any
of the P. vivax–infected placentas.
Histology of the 10 placentas that were positive by qPCR
only for P. falciparum showed 1 biopsy with no parasites or
Table 1. Placental Histology and Quantitative Polymerase
Chain Reaction (qPCR) in Peripheral Blood From Women With
qPCR-Conﬁrmed Plasmodium Species Infection in Intervillous
Placental Blood Samples
Placental
Infection (qPCR)a Placental Histology
Peripheral
Infection (qPCR)a
8 only P. vivax 3 parasites Negative
3 hemozoin in fibrin Negative
1 parasites + hemozoin
in fibrin
P. falciparum
1 negative Negative
10 only
P. falciparum
2 parasites Negative
7 parasites + hemozoin
in free macrophages
and fibrin
6 P. falciparum
1 negative Negative
1 P. falciparum
+ P. vivax
1 parasites + hemozoin
in free macrophages
and fibrin
Negative
aPlasmodium vivax and Plasmodium falciparum infections de-
tected by qPCR were conﬁrmed by PCR ligase detection reac-
tion ﬂuorescent microsphere assay.
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hemozoin; 2 with only malaria IEs; and 7 with malaria IEs
and hemozoin in free macrophages and ﬁbrin. Among those
with IEs, placental parasitemias were 1% (4 placentas), 2%,
4%, 15% (1 placenta each), and 25% (2 placentas). Six of the 7
women with placental IEs and hemozoin in free macrophages
and ﬁbrin also had a P. falciparum peripheral infection (Table 1).
In the placenta with mixed P. falciparum plus P. vivax infec-
tion detected by qPCR, both IEs and hemozoin in macrophages
and ﬁbrin were observed by histology. No Plasmodium species
were detected in peripheral blood of this woman (Table 1).
Histological examination did not allow discrimination
between P. vivax and P. falciparum IEs (Figure 2). None of the
placentas with P. vivax monoinfections detected by qPCR
showed increased leukocytes (CD45) or macrophages (CD68)
(Figure 3A and 3B) compared with uninfected placentas
(Figure 4). In contrast, a signiﬁcant number of P. falciparum–
monoinfected placentas showed a moderate to marked increase
in the number of total leukocytes (n = 5) and macrophages
(n = 3) in the intervillous space (Figure 3C and 3D), compared
with uninfected placentas (Figure 4).
DISCUSSION
The data presented constitute a detailed molecular and histo-
logical characterization of P. vivax infection in the placenta.
Figure 2. Comparison between Plasmodium vivax (A, B, and C ) and Plasmodium falciparum (A′, B′ , and C′) parasitized placentas. A and A′ show
maternal infected red blood cells in the intervillous space. No inﬂammatory reaction was observed in P. vivax–infected placenta, whereas an increased
number of intervillous macrophages were detected in P. falciparum–infected placenta. B and B ′ show the same ﬁelds under polarized light showing the
birefringence of hemozoin present in the mature forms of the parasites. Birefringent hemozoin in free macrophages was present in the P. falciparum–
infected placenta. C and C ′, Higher magniﬁcation showing the characteristics of the parasites.
Figure 1. Histological sections of placentas with Plasmodium vivax
monoinfections showing parasitized maternal red blood cells. All para-
sites identiﬁed were mature forms containing hemozoin (A and B ). C,
Malarial hemozoin in perivillous ﬁbrin in a case positive for P. vivax by
quantitative polymerase chain reaction. D, Malarial hemozoin showing
birefringence under polarized light.
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Ten percent of placental blood samples (8 of 80) showed
P. vivax monoinfection by qPCR. Histological examination of
3 of these placentas showed malaria IEs in the intervillous
space. Plasmodium falciparum monoinfection was detected in
12% (10 of 80) of the placental blood samples, 9 of which
were associated with the presence of malaria IEs by histology.
Only 1 placental sample had a mixture of both P. falciparum
and P. vivax. The 3 P. vivax placental monoinfections con-
ﬁrmed by histology were not associated with a concomitant
infection in peripheral blood, in contrast to 6 of the 9 women
with P. falciparum placental monoinfections who also present-
ed a qPCR-conﬁrmed P. falciparum infection in peripheral
blood. Absence of P. vivax peripheral infection in women with
P. vivax placental monoinfection may be explained by low
P. vivax peripheral densities below or ﬂuctuating around the
detection limit of qPCR. Alternatively, the absence of parasites
in peripheral blood may suggest that P. vivax can persist in
the placenta even after parasite clearance in the circulation
and that P. vivax might be able to selectively sequester in the
placenta.
Three of the 8 placentas with qPCR-conﬁrmed P. vivax
monoinfections showed hemozoin in ﬁbrin but no parasites in
the histological examination. Although the presence of DNA
in hemozoin complexes [28] may explain these cases positive
by PCR but negative by histology, it is not possible to know
with certainty whether the hemozoin corresponds to recent
P. vivax infection or a past P. falciparum infection. In this
study, parasites and hemozoin deposition in free macrophages
and ﬁbrin were detected by histology in 7 of the 9 (78%)
women with qPCR-conﬁrmed P. falciparum placental
Figure 3. Immunohistochemical staining macrophages (CD68) in Plas-
modium vivax–infected (A and B) and Plasmodium falciparum–infected
(C and D) placentas.
Figure 4. Number of CD45+ (leukocytes) and CD68+ (macrophages) cells after examination of 10 high-power ﬁelds (HPF; ×400) in placentas with
Plasmodium vivax and Plasmodium falciparum monoinfection and uninfected placentas. Median cell counts and interquartile ranges are indicated by
horizontal continuous and dashed lines.
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infection, but only in 1 of the 4 women with qPCR-conﬁrmed
P. vivax placental infection. However, the fact that this latter
woman was also infected by P. falciparum in the peripheral
blood means it is not possible to conclude whether the hemo-
zoin resulted from the P. vivax or P. falciparum infection. Al-
though a previous report showed moderate placental
deposition of hemozoin in Karen women with antenatal
P. vivax infections [20], that study could only conﬁrm by his-
tology the presence of malaria IEs in 1 placenta, probably
as a result of the active detection and treatment of women
included in that study [20].
The absence of hemozoin deposition and accumulation of
inﬂammatory cells in placentas infected with P. vivax observed
in the present study may suggest that placental P. vivax infec-
tions occurred during late pregnancy. Alternatively, P. vivax
parasites may not remain in the placenta long enough to cause
hemozoin deposition and trigger the accumulation of inﬂam-
matory cells. Overall, this study suggests that factors other
than persistent pathological disturbances of the placenta, such
as systemic alterations, may cause the reduction of birth
weight associated with P. vivax infection [24].
There are 4 main limitations of the current study. First, the
small sample size did not allow statistical comparisons of his-
tological ﬁndings between P. vivax– and P. falciparum–infected
placentas. Second, it is not possible to exclude the presence of
parasites in other sections of the placenta, as only a small
section was examined by histology. Third, all the analysis was
done with samples at delivery, as blood was not available
during pregnancy to assess the presence of Plasmodium infec-
tion. And fourth, Plasmodium parasites, particularly P. vivax,
which reaches lower densities than P. falciparum, may be
present at densities below the detection limit of qPCR, making
their detection by histology and even qPCR challenging.
In conclusion, this study shows the presence of P. vivax par-
asites in the placenta by histology while excluding infection
with other Plasmodium species by 2 independent and highly
speciﬁc molecular methods. This demonstrates for the ﬁrst
time that P. vivax, although at a lower frequency than
P. falciparum, can be associated with placental infection. Im-
portantly, histological examination of placentas with P. vivax
monoinfections and absence of P. falciparum in peripheral
blood detected only parasites but not hemozoin in macro-
phages, in contrast to the observation of both parasites and
hemozoin in P. falciparum monoinfections. Moreover, the
presence of P. vivax in the placenta was not associated with
an increase of inﬂammatory cell inﬁltrates in contrast to
P. falciparum placental infections [20]. Even though inﬂam-
matory changes were not observed with P. vivax infections,
the parasite or its products may have an adverse effect on pla-
cental function. Further studies are under way to establish the
clinical consequences of P. vivax in pregnant women on preg-
nancy outcomes.
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